Full Text
Full text is available in PDF
Nephro-Urology Monthly
Insertion of Intraprostate Gold Fiducial Markers in Prostate Cancer Treatment
Author(s):
Joaqun Ulises Juan Escudero1,*, 
Jorge Pastor Peidro2, Macarena Ramos de Campos2, Jose Lopez Torrecilla2, Emilio Lopez Alcina2, Pedro Navaln Verdejo2, Milagros Fabuel Deltoro2, Emilio Marques Vidal21Urology, Consorcio Hospital General de Valencia, [email protected], Spain
2Radiotherapic Oncology, ERESA, Spain
Published online:Jan 31, 2010
Article type:Research Article
Received:Jun 29, 2009
Accepted:Jun 19, 2009
How to Cite:Escudero J, Peidro J, de Campos M, Torrecilla J, Alcina E, et al. Insertion of Intraprostate Gold Fiducial Markers in Prostate Cancer Treatment. Nephro-Urol Mon. 2010;2(1):. doi:
Abstract
Copyright
© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
31
Aug
2017
Ultrasound Image Based High Dose Rate (HDR) Brachytherapy in Locally Advanced Cancer Cervix
R.K. Spartacus,
Rohitashwa Dana,
Pradeep Gaur,
Devesh Gupta,
Rajan Paliwal,
Shweta Mutha
Spartacus R, Dana R, Gaur P, Gupta D, Paliwal R, et al. Ultrasound Image Based High Dose Rate (HDR) Brachytherapy in Locally Advanced Cancer Cervix. Int J Cancer Manag. 2017;10(8):e7392. doi: https://doi.org/10.5812/ijcm.7392
17
May
2026
Can Deformable Image Registration Improve Cumulative Dose Assessment and Enable Safer Dose Escalation in Rectal Cancer Radiotherapy? A Retrospective Cohort Study
Mehdi Eslamizadeh,
Mohamad Dosaranian-Moghadam,
Seyed Vahab Shojadini,
Somayeh Raeis Dana
Eslamizadeh M, Dosaranian-Moghadam M, Shojadini SV, Raeis Dana S. Can Deformable Image Registration Improve Cumulative Dose Assessment and Enable Safer Dose Escalation in Rectal Cancer Radiotherapy? A Retrospective Cohort Study. Int J Cancer Manag. 2026;19(1):e168776. doi: https://doi.org/10.5812/ijcm-168776
7
Aug
2019
Level of Prostate Cancer Diagnosis Using MRI-TRUS Fusion Biopsy in Patients with a Negative History of TRUS Biopsy
Alireza Lashey,
Said Yaghoob Sehri,
Ahmad Aghai Meibodi,
Mahyar Ghafari,
Jafar Gholivandan,
Mohamad Solymani
,et al.Lashey A, Sehri SY, Aghai Meibodi A, Ghafari M, Gholivandan J, et al. Level of Prostate Cancer Diagnosis Using MRI-TRUS Fusion Biopsy in Patients with a Negative History of TRUS Biopsy. Nephro-Urol Mon. 2019;11(3):e93596. doi: https://doi.org/10.5812/numonthly.93596
28
Feb
2014
Imaging Evaluation of Recurrence in Treated Prostate Cancer
Mahyar Ghafoori
Ghafoori M. Imaging Evaluation of Recurrence in Treated Prostate Cancer. I J Radiol. 2014;11(30th Iranian Congress of Radiology):e21413. doi: https://doi.org/10.5812/iranjradiol.21413
19
May
2022
Evaluation of the Relationship Between Prostate-Specific Antigen Levels, Gleason Scores, and 68Ga-PSMA PET/CT Scan Findings in Prostate Cancer Patients
Abtin Doroudinia,
Najmeh Darvishian,
Mehrdad Bakhshayesh Karam,
Habib Emami
Doroudinia A, Darvishian N, Bakhshayesh Karam M, Emami H. Evaluation of the Relationship Between Prostate-Specific Antigen Levels, Gleason Scores, and 68Ga-PSMA PET/CT Scan Findings in Prostate Cancer Patients. I J Radiol. 2022;19(1):e122440. doi: https://doi.org/10.5812/iranjradiol-122440
Comments
Number of Comments:0Cited by
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 0
Last Update: 1 week ago
- Scopus by Title (Ref): 1
Last Update: 1 week ago
- CrossRef: 0
Last Update: 4 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Search Relations
Author(s):
Related Articles